3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension

Abroad (travel likely)Recruiting

Conditions

Cirrhosis, Liver · Portal Hypertension · Advanced Chronic Liver Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shengjing Hospital, Shenyang, Liaoning, China
Contact: Study coordinator (Yifei Huang, MD) · huangyf1995@foxmail.com

Study leads

Yu Shi, Prof.
Principal Investigator
Shengjing Hospital
Shenghong Ju, Prof.
Principal Investigator
Zhongda Hospital
Xiaolong Qi, Prof.
Principal Investigator
Zhongda Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG

Portal Hypertension · Chronic Liver Disease (CLD) · Cirrhosis

Abroad (travel likely)Recruiting

Barcelona, Spain

Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

Hepatic Encephalopathy · Cirrhosis, Liver · Portal Hypertension

Abroad (travel likely)RecruitingPHASE4

Leuven, Belgium · Amsterdam, Netherlands

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Liver Disease; Alcohol-Related · Cirrhosis · Alcohol Use Disorder

Abroad (travel likely)RecruitingPHASE1, PHASE2

Richmond, United States · Richmond, United States

Austrian PBC Registry

Primary Biliary Cholangitis · Liver Cirrhosis · Portal Hypertension

Abroad (travel likely)Recruiting

Klagenfurt, Austria · Sankt Pölten, Austria